Europe Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

the Report Covers European Insulin Delivery Devices Market Trends and It is Segmented by Device (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors) and Geography. the Report Offers the Market Size in Value Terms in USD and the Volume in Units for all the Abovementioned Segments.

Europe Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Europe Insulin Delivery Devices Market Size

View Global Report
Europe Insulin Delivery Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 2.88 Billion
Market Size (2030) USD 3.17 Billion
CAGR (2025 - 2030) 1.90 %

Major Players

Europe Insulin Delivery Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Europe Insulin Delivery Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Europe Insulin Delivery Devices Market Analysis

The Europe Insulin Delivery Devices Market size is estimated at USD 2.88 billion in 2025, and is expected to reach USD 3.17 billion by 2030, at a CAGR of 1.9% during the forecast period (2025-2030).

During the COVID-19 pandemic, patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, metabolic comorbidities, and more severe illness from SARS-CoV-2 infection. According to an article, “Costs of COVID-19 Pandemic associated with Diabetes in Europe: A Health Care Cost Model,” published in 2021, the estimated cost per hospital admission during the first wave of COVID-19 in Europe ranged from EUR 25,018 (USD 26,744.24) for type 2 diabetes patients in good glycemic control to EUR 57,244 (USD 61,193.84) for type 1 diabetes patients in poor glycemic control, reflecting a higher risk of intensive care, ventilator support, and a longer hospital stay. The estimated cost for patients without diabetes was EUR 16,993 (USD 18,165.52). The expected total direct expenditures for COVID-19 secondary care in Europe were 13.9 billion euros (USD 14.86 billion). Diabetes treatment thus accounted for 23.5% of total expenditures.

Insulin is a hormone that controls blood sugar levels by signaling the liver mus,cle, and fat cells to take in glucose from the blood. It helps cells take in glucose to be used for energy. Type 1 diabetes is when the pancreas produces too little insulin to meet the body's requirements. Type 1 diabetes management is complex and highly individualized. People with Type 1 diabetes need synthetic insulin every day or multiple times a day to control blood sugar levels. Type 1 diabetes makes up 5 to 15% of the total diabetes population, and prevention ways have not yet been defined. Screening for type 1 diabetes is essential for an effective management strategy. Treatment for type 1 diabetes includes daily multiple injections of insulin or using an insulin delivery device.

Technological advancements in insulin delivery devices have increased for safer and more accurate insulin administration. In April 2021, Medtronic introduced the Medtronic Extended infusion set in selected European countries as the first and only infusion set that may be worn for up to 7 days. An infusion set is tubing that delivers insulin from the pump to the body and typically requires a set change every few days. This innovation doubles the time an infusion set may be worn so users can safely stay on insulin pump therapy with fewer interruptions and insertions while introducing enhanced convenience and comfort to their diabetes management routine. The set is compatible with all MiniMed 600 and 700 series insulin pumps.

Therefore, owing to the aforementioned factors, the market studied is anticipated to grow over the analysis period.

European Insulin Delivery Devices Industry Overview

The European insulin delivery devices market is consolidated due to the presence of only a few major companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, including Novo Nordisk, Sanofi, Eli Lily and Company, Medtronic, Insulet, Ypsomped, and Becton Dickinson and Company.

Europe Insulin Delivery Devices Market Leaders

  1. Eli Lilly and Company

  2. Medtronic PLC

  3. Sanofi Aventis

  4. Becton Dickinson and Company

  5. Novo Nordisk A/S

  6. *Disclaimer: Major Players sorted in no particular order
Europe Insulin Delivery Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Europe Insulin Delivery Devices Market News

  • October 2022: Medtronic introduced a new program called My Insights, which is exclusively made for individuals using the MiniMed 770G system. Using an individual's data, My Insights relies on the power of data science to provide personalized tips, trends, and reminders that customers can use to help with their diabetes management goals. My Insights personalized recommendations are shared via a monthly email with educational content that is most relevant to what an individual may currently be experiencing. This is the first program in diabetes management that goes beyond generalized tips and instead shares personalized suggestions using data from an integrated pump system.
  • April 2022: CamDiab and Ypsomed announced the partnership to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of diabetes management for people with diabetes in European countries. The new integrated AID system is designed to connect Abbott's FreeStyle Libre 3 sensor, the world's most miniature and most accurate continuous glucose monitoring sensor, to CamDiab's CamAPS FX mobile app, which connects with Ypsomed's mylife YpsoPump, creating a smart, automated process to deliver insulin based on real-time glucose data. The connected, smart wearable solution is designed to continuously monitor a person's glucose levels and automatically adjust and have the right amount of insulin at the right time, removing the guesswork of insulin dosing.

Europe Insulin Delivery Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Device
    • 5.1.1 Insulin Pumps
    • 5.1.1.1 By Technology
    • 5.1.1.1.1 Tethered Insulin Pump
    • 5.1.1.1.2 Tubless Insulin Pump
    • 5.1.1.2 By Component
    • 5.1.1.2.1 Insulin Pump Device
    • 5.1.1.2.2 Reservoir
    • 5.1.1.2.3 Infusion Sets
    • 5.1.2 Insulin Syringes
    • 5.1.3 Insulin Pens
    • 5.1.3.1 Reusable Pens
    • 5.1.3.2 Disposable Pens
    • 5.1.4 Jet Injectors
  • 5.2 Geography
    • 5.2.1 France
    • 5.2.2 Germany
    • 5.2.3 Italy
    • 5.2.4 Russia
    • 5.2.5 Spain
    • 5.2.6 United Kingdom
    • 5.2.7 Rest of Europe

6. MARKET INDICATORS

  • 6.1 Type 1 Diabetes Population
  • 6.2 Type 2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Novo Nordisk AS
    • 7.1.2 Sanofi
    • 7.1.3 Eli Lilly and Company
    • 7.1.4 Medtronic PLC
    • 7.1.5 Insulet Corporation
    • 7.1.6 Ypsomed
    • 7.1.7 Becton Dickinson and Company
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Novo Nordisk AS
    • 7.2.2 Sanofi
    • 7.2.3 Eli Lilly and Company
    • 7.2.4 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Insulin Delivery Devices Industry Segmentation

There are different ways to inject insulin into a patient’s body, using syringes, pens, pumps, and jet injectors, giving them various options for insulin delivery. The European insulin delivery devices market is segmented by device (insulin pumps, insulin syringes, cartridges in reusable pens, disposable pens, and jet injectors) and geography. The report offers the market size in value terms in USD and the volume in units for all the abovementioned segments.

By Device Insulin Pumps By Technology Tethered Insulin Pump
Tubless Insulin Pump
By Component Insulin Pump Device
Reservoir
Infusion Sets
Insulin Syringes
Insulin Pens Reusable Pens
Disposable Pens
Jet Injectors
Geography France
Germany
Italy
Russia
Spain
United Kingdom
Rest of Europe
Need A Different Region or Segment?
Customize Now

Europe Insulin Delivery Devices Market Research Faqs

How big is the Europe Insulin Delivery Devices Market?

The Europe Insulin Delivery Devices Market size is expected to reach USD 2.88 billion in 2025 and grow at a CAGR of 1.9% to reach USD 3.17 billion by 2030.

What is the current Europe Insulin Delivery Devices Market size?

In 2025, the Europe Insulin Delivery Devices Market size is expected to reach USD 2.88 billion.

Who are the key players in Europe Insulin Delivery Devices Market?

Eli Lilly and Company, Medtronic PLC, Sanofi Aventis, Becton Dickinson and Company and Novo Nordisk A/S are the major companies operating in the Europe Insulin Delivery Devices Market.

What years does this Europe Insulin Delivery Devices Market cover, and what was the market size in 2024?

In 2024, the Europe Insulin Delivery Devices Market size was estimated at USD 2.83 billion. The report covers the Europe Insulin Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Insulin Delivery Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Europe Insulin Delivery Devices Industry Report

Statistics for the 2025 Europe Insulin Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Insulin Delivery Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.